Curapath (formerly Polypeptide Therapeutics Solutions) is a CDMO that provides clients with the development of novel drug delivery systems. Curapath is experienced in developing analytical methods for the formulation and manufacturing of LNPs and PNPs. The company supports manufacturing and testing for both drug substance and drug product, helping their partners from development to IND. This includes development from proof-of-concept to preclinical, clinical, and commercial-scale GMP manufacturing. Founded in 2013, the company is headquartered in Valencia, Spain, with additional facilities in Cambridge, Massachusetts.